75 results
Page 4 of 4
8-K
8kldbfykv 0inq
8 Oct 19
Regulation FD Disclosure
4:26pm
DEFA14A
5u3 xmwkb
4 Oct 19
Additional proxy soliciting materials
4:55pm
8-K
318orszikh01z3hzgrxj
4 Oct 19
Chardan Advises Health Sciences Acquisitions Corporation on Merger with Immunovant
4:53pm
PREM14A
2ap3vj09jfl
2 Oct 19
Preliminary proxy related to merger
9:58am
8-K
EX-99.1
4lbmtu4
2 Oct 19
Creating New Publicly Listed FcRn-Focused Company
7:30am
8-K
EX-2.1
fhzmj8c5j99t3ss80x
2 Oct 19
Creating New Publicly Listed FcRn-Focused Company
7:30am
8-K
swvcp49k8mvmkw8vc
2 Oct 19
Creating New Publicly Listed FcRn-Focused Company
7:30am
DEFA14A
EX-99.1
6lbdn11ky7o yw
2 Oct 19
Additional proxy soliciting materials
7:28am
DEFA14A
EX-2.1
gfgzt17z9a93 lru3c
2 Oct 19
Additional proxy soliciting materials
7:28am
DEFA14A
mxhon hyry8tdcsw6ju
2 Oct 19
Additional proxy soliciting materials
7:28am
424B4
feef81c
10 May 19
Prospectus supplement with pricing info
5:18pm
S-1
1hsagh
15 Apr 19
IPO registration
9:56pm
DRS/A
31lw15vtnktpnj
26 Feb 19
Draft registration statement (amended)
12:00am
DRS
yyoeusfd9kft42
23 Jan 19
Draft registration statement
12:00am